News

Epify Strengthens Management Team by Appointing Leander Van Neste as Chief Scientific Officer

Epify Strengthens Management Team by Appointing Leander Van Neste as Chief Scientific Officer

Maastricht, The Netherlands, November 7, 2019 -- Epify BV is a recently established biotechnology company that translates sound epigenetic biomarker discoveries into clinical practice to...
Read more
Official launch of OHMX.bio, partner for high-throughput OMICS solutions

Official launch of OHMX.bio, partner for high-throughput OMICS solutions

Ghent, 14 October 2019. Novalis and Ghent University are proud to release OHMX.bio (www.ohmx.bio), the sixth instalment in Novalis’ portfolio of biotechnology and life sciences...
Read more
Novalis participates in financing round of FERTIGA for further expansion of the Corona Test

Novalis participates in financing round of FERTIGA for further expansion of the Corona Test

Ghent, Belgium, 09 Oct 2019. Fertiga, the Belgian female fertility company, announces the closure of its first financing round together with Novalis Biotech Incubation and...
Read more
Epify raises 500,000 Euro in seeding round

Epify raises 500,000 Euro in seeding round

Maastricht, 26 September 2019.  Epify is a recently established biotech company that translates sound epigenetic biomarker discoveries into clinical practice to help doctors improve the...
Read more
AI Meets Genome Sequencing and the Health Data Explosion to Transform Medicine

AI Meets Genome Sequencing and the Health Data Explosion to Transform Medicine

We’ve discussed the questions of “nature vs nurture”, personalized medicine and the privacy of genomics data with Dr. Wim Van Criekinge, Chief Life Science Officer...
Read more
Wobblebase genome importer from Novalis integrated in doc.ai medical data platform

Wobblebase genome importer from Novalis integrated in doc.ai medical data platform

In October 2018, Wobblebase’s genome importer has been integrated in the doc.ai platform. Biotech incubator Novalis is now the second largest external shareholder in doc.ai.
Read more
MyNeo has been officially launched today!

MyNeo has been officially launched today!

Ghent, 27th December 2018. MyNeo has started its life as an independent entity! MyNeo is a Belgian biotech company, based in Ghent, focused on identifying,...
Read more
Launch of BioLizard’s website, lizard.bio!

Launch of BioLizard’s website, lizard.bio!

Today we announce the launch of lizard.bio, where we describe our experience in bioinformatics, biostatistics and machine learning, applied to the biotechnology field.
Read more
De Tijd interviews Novalis’s founders

De Tijd interviews Novalis’s founders

De Tijd journalist Jan De Schamphelaere discusses the launch of Novalis with our founders, from their previous careers to the current state of the fund.
Read more
Novalis founds first three companies

Novalis founds first three companies

We are proud to announce to the world the incorporation of BioLizard, OHMX.bio and MyNeo.
Read more
Novalis becomes a member of flanders.bio

Novalis becomes a member of flanders.bio

Novalis makes its entry in the Flemish biotech scene, and invites resumés to fill various positions. We’re also interested in learning about your latest research,...
Read more
Tijd article gives extra weight to Novalis’ mission

Tijd article gives extra weight to Novalis’ mission

Met een stroom positief nieuws kregen we de voorbije week weer een biotechbonanza. Jo Bury en Rudy Dekeyser, de founding fathers van het Vlaams Instituut...
Read more